Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Everyone is missing the point of this trial. This isn’t an advertise for enrollment clinical trial. Enrollees don’t just show up sick after enrolling and participate at a clinical site.

These are ER patients at hospitals who are then asked if they want to take an experimental drug for Covid-19. If yes, the screening is quick following confirmation of SARS-CoV-2 infection, and the first dose is administered within hours of hospital admission. Very few patients are going to turn down an experimental drug for a pathogen that had only a marginally effective drug, Remdesivir, as a treatment. A hundred patients could fully enroll and complete treatment in a week. Completion of the trial would be a month later.